---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-025691"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2023-06-01T23:59:59+00:00"
generated_at: "2026-06-14T09:10:37.998623+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Larimar Therapeutics posts updated corporate presentation for investor meetings

## Summary
- Updated slide presentation posted on company website on June 1, 2023.
- No specific changes or material updates disclosed in the filing or attached exhibit.
- Presentation intended for use in meetings with investors and analysts.

## SEC filing metadata
- accession: 0000950170-23-025691
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2023-06-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000095017023025691/0000950170-23-025691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000095017023025691/lrmr-20230601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-025691
- JSON: https://secwatch.observer/filing/0000950170-23-025691.json
- Plain text: https://secwatch.observer/filing/0000950170-23-025691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.